The Ethics of Biobanks

Due to modern biochemistry and, in particular, recent developments in genomics, proteomics, and bioinformatics, human samples (organs, tissues, cells, genes, etc.) have become the most important raw materials for advancement in the health sciences. Such material has been at the center of fundamental...

Full description

Saved in:  
Bibliographic Details
Main Author: Hansson, Sven Ove (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Interlibrary Loan:Interlibrary Loan for the Fachinformationsdienste (Specialized Information Services in Germany)
Published: 2004
In: Cambridge quarterly of healthcare ethics
Year: 2004, Volume: 13, Issue: 4, Pages: 319-326
Online Access: Volltext (lizenzpflichtig)
Volltext (lizenzpflichtig)

MARC

LEADER 00000naa a22000002c 4500
001 1827971126
003 DE-627
005 20221220052638.0
007 cr uuu---uuuuu
008 221220s2004 xx |||||o 00| ||eng c
024 7 |a 10.1017/S0963180104134038  |2 doi 
035 |a (DE-627)1827971126 
035 |a (DE-599)KXP1827971126 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Hansson, Sven Ove  |e VerfasserIn  |4 aut 
245 1 4 |a The Ethics of Biobanks 
264 1 |c 2004 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a Due to modern biochemistry and, in particular, recent developments in genomics, proteomics, and bioinformatics, human samples (organs, tissues, cells, genes, etc.) have become the most important raw materials for advancement in the health sciences. Such material has been at the center of fundamental biomedical research for a long time. What is new is its increased usefulness in research with direct clinical relevance, such as the development of drugs. Because of the larger commercial involvement in such research, this has also led to greater economic interests in human biological material and in the information that can be extracted from it. 
601 |a Biobank 
773 0 8 |i Enthalten in  |t Cambridge quarterly of healthcare ethics  |d Cambridge : Cambridge Univ. Press, 1992  |g 13(2004), 4, Seite 319-326  |h Online-Ressource  |w (DE-627)306655039  |w (DE-600)1499985-7  |w (DE-576)081985010  |x 1469-2147  |7 nnas 
773 1 8 |g volume:13  |g year:2004  |g number:4  |g pages:319-326 
856 4 0 |u https://doi.org/10.1017/S0963180104134038  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.cambridge.org/core/journals/cambridge-quarterly-of-healthcare-ethics/article/ethics-of-biobanks/348D413335B900473ABF28977B7A52A3  |x Verlag  |z lizenzpflichtig  |3 Volltext 
935 |a mteo 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4235376039 
LOK |0 003 DE-627 
LOK |0 004 1827971126 
LOK |0 005 20221220052638 
LOK |0 008 221220||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-Tue135)IxTheo#2022-12-06#AEACFB565B1AE9C898249D15021F995A5AF30274 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 935   |a ixzs  |a ixrk  |a zota 
ORI |a SA-MARC-ixtheoa001.raw